{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:53:41Z","timestamp":1791993221086,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cardfail.2025.03.018","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T12:23:10Z","timestamp":1744806190000},"page":"586-595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["NT-proBNP in the Early Convalescent Phase after High-Risk Myocardial Infarction Is Associated with Adverse Cardiovascular Outcomes: the PARADISE-MI Trial"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5243-1959","authenticated-orcid":false,"given":"KAROLA S.","family":"JERING","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BRIAN L.","family":"CLAGGETT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EUGENE","family":"BRAUNWALD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHRISTOPHER B.","family":"GRANGER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LARS","family":"K\u00d8BER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ULF","family":"LANDMESSER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ELDRIN F.","family":"LEWIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALDO P.","family":"MAGGIONI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DOUGLAS L.","family":"MANN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOHN JV","family":"MCMURRAY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROXANA","family":"MEHRAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARK C.","family":"PETRIE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARGARET F.","family":"PRESCOTT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JEAN L.","family":"ROULEAU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MORTEN","family":"SCHOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SCOTT D","family":"SOLOMON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PHILIPPE GABRIEL","family":"STEG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DIRK","family":"VON\u202fLEWINSKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARC A.","family":"PFEFFER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.cardfail.2025.03.018_bib0001","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.cardfail.2025.03.018_bib0002","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/CIRCULATIONAHA.115.018931","article-title":"Trends in mortality from ischemic heart disease and cerebrovascular disease in Europe: 1980 to 2009","volume":"133","author":"Hartley","year":"2016","journal-title":"Circulation"},{"issue":"42","key":"10.1016\/j.cardfail.2025.03.018_bib0003","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","article-title":"Cardiovascular disease in Europe: epidemiological update 2016","volume":"37","author":"Townsend","year":"2016","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.cardfail.2025.03.018_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021682","article-title":"Trends in premature mortality from acute myocardial infarction in the United States, 1999 to 2019","volume":"11","author":"Dani","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.cardfail.2025.03.018_bib0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.CIR.0000079170.10579.DC","volume":"108","author":"James","year":"2003","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.cardfail.2025.03.018_bib0006","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1161\/01.CIR.0000041661.63285.AE","article-title":"N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes","volume":"106","author":"Omland","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.cardfail.2025.03.018_bib0007","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/01.CIR.0000134480.06723.D8","article-title":"N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes","volume":"110","author":"Galvani","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cardfail.2025.03.018_bib0008","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.010259","article-title":"Prognostic importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) following high-risk myocardial infarction in the PARADISE-MI Trial","volume":"16","author":"Jering","year":"2023","journal-title":"Circ Heart Fail"},{"issue":"18","key":"10.1016\/j.cardfail.2025.03.018_bib0009","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1053\/euhj.1999.2045","article-title":"Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction","volume":"21","author":"Talwar","year":"2000","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.cardfail.2025.03.018_bib0010","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1001\/jama.294.22.2866","article-title":"Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease","volume":"294","author":"Morrow","year":"2005","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.cardfail.2025.03.018_bib0011","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jacc.2004.10.057","article-title":"Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy","volume":"45","author":"Lindahl","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.cardfail.2025.03.018_bib0012","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1161\/01.CIR.0000147611.92021.2B","article-title":"N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes","volume":"110","author":"Heeschen","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cardfail.2025.03.018_bib0013","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ejhf.2191","article-title":"Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics","volume":"23","author":"Jering","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"20","key":"10.1016\/j.cardfail.2025.03.018_bib0014","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa2104508","article-title":"Angiotensin receptor-neprilysin inhibition in acute myocardial infarction","volume":"385","author":"Pfeffer","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.cardfail.2025.03.018_bib0015","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.cardfail.2025.03.018_bib0016","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2025.03.018_bib0017","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ahj.2023.08.007","article-title":"Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials","volume":"266","author":"Newman","year":"2023","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.cardfail.2025.03.018_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000907","article-title":"B-type natriuretic peptides for the prediction of cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study","volume":"3","author":"Mishra","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.cardfail.2025.03.018_bib0019","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jacc.2007.03.038","article-title":"Prognostic value of B-type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial","volume":"50","author":"Omland","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.cardfail.2025.03.018_bib0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1139\/y06-102","article-title":"Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline?","volume":"85","author":"Ezekowitz","year":"2007","journal-title":"Can J Physiol Pharmacol"},{"issue":"13","key":"10.1016\/j.cardfail.2025.03.018_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016033","article-title":"Novel biomarkers, ST-elevation resolution, and clinical outcomes following primary percutaneous coronary intervention","volume":"9","author":"Shavadia","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.cardfail.2025.03.018_bib0022","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijcard.2009.09.537","article-title":"Predictive value of NT-pro BNP after acute myocardial infarction: relation with acute and chronic infarct size and myocardial function","volume":"147","author":"Mayr","year":"2011","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.cardfail.2025.03.018_bib0023","doi-asserted-by":"crossref","first-page":"1093.e1","DOI":"10.1016\/j.ahj.2005.12.020","article-title":"NT-probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non-ST-elevation acute coronary syndromes","volume":"151","author":"Navarro Estrada","year":"2006","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.cardfail.2025.03.018_bib0024","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.amjcard.2005.11.029","article-title":"N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis","volume":"97","author":"Ndrepepa","year":"2006","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.cardfail.2025.03.018_bib0025","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.cardfail.2011.02.006","article-title":"Amino-terminal pro-B-type natriuretic peptide (NT-proBNP) levels 3 months after myocardial infarction are more strongly associated with magnetic resonance-determined ejection fraction than NTproBNP levels in the acute phase","volume":"17","author":"Mistry","year":"2011","journal-title":"J Card Fail"},{"issue":"3","key":"10.1016\/j.cardfail.2025.03.018_bib0026","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.113.004420","volume":"129","author":"Wallentin","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cardfail.2025.03.018_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2015.02.019","article-title":"Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial","volume":"169","author":"Velders","year":"2015","journal-title":"Am Heart J"},{"issue":"41","key":"10.1016\/j.cardfail.2025.03.018_bib0028","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1093\/eurheartj\/ehac494","article-title":"Empagliflozin in acute myocardial infarction: the EMMY trial","volume":"43","author":"von Lewinski","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2025.03.018_bib0029","doi-asserted-by":"crossref","unstructured":"Butler J, Jones WS, Udell JA, et al. Empagliflozin after acute myocardial infarction. New Engl J Med 0(0). https:\/\/doi.org\/10.1056\/NEJMoa2314051","DOI":"10.1056\/NEJMoa2314051"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425001642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425001642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:31:46Z","timestamp":1773135106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916425001642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1071916425001642"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.03.018","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NT-proBNP in the Early Convalescent Phase after High-Risk Myocardial Infarction Is Associated with Adverse Cardiovascular Outcomes: the PARADISE-MI Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}